Skip to content

Vitoss 2102-0010Recalls & reported problems

Stryker Corporation · Bone Graft Substitute, 1-4mm Morsels, Beta-Tricalcium Phosphate · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00808232000122), received between Dec 13, 2016 and Dec 13, 2016 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Expiration Issue” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Device Expiration Issue1
  • Expiration Date Error1
  • Inadequate User Interface1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 13, 2016Device Expiration Issue; Device Expiration Issue; Expiration Date Error; Inadequate User Interface

    IT WAS REPORTED THAT "AN EXPIRED CEMENT (EXPIRY DATE = (B)(6) 2016) WAS IMPLANTED INTO A PATIENT DURING A PROCEDURE." THE SURGEON WANTS TO CONFIRM IF THERE IS ANY POTENTIAL RISK FOR THE PATIENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6170149 ↗

Other FILLER, BONE VOID, CALCIUM COMPOUND devices

All FILLER, BONE VOID, CALCIUM COMPOUND devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.